Increased food intake and energy expenditure following administration of olanzapine to healthy men.

Obesity (Silver Spring, Md.)

Volumn 18, Issue 8, 2010, Pages 1646-1651

  Fountaine, Robert J ^a   Taylor, Ann E ^b   Mancuso, James P ^b   Greenway, Frank L ^b   Byerley, Lauri O ^b   Smith, Steven R ^b   Most, Marlene M ^b   Fryburg, David A ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BIOLOGICAL MARKER; LEPTIN; NEUROLEPTIC AGENT; OLANZAPINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BASAL METABOLIC RATE; BLOOD; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BASAL METABOLISM; BENZODIAZEPINES; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; ENERGY INTAKE; EXERCISE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; REFERENCE VALUES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN; YOUNG ADULT;

EID: 85027951242     PISSN: 19307381     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2010.6     Document Type: Article

References (0)